Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 236 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-02 2023-06-02 185930
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-06 2023-06-02 188968
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-27 2023-06-02 190862
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-05-19 2023-06-02 192788
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-06-29 2023-11-06 196949
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-07-21 2023-11-06 199515
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-08 2024-02-23 212934
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213553
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213576
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-01-05 214223
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-02-23 214235
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2024-04-12 2024-04-26 225008
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2017-08-24 2017-09-22 20281
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2018-01-18 2018-02-12 36432
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2018-03-13 2018-07-03 42717
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-04-13 2020-05-22 111901
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-05-08 2020-05-22 114285
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-06-04 2020-07-28 116533
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-08-06 2020-11-28 121891
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2023-09-07 2023-09-15 203819

Showing 3001 to 3020 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 41 to 60 of 356